Hammond S - Search Results

1

How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse.

Godfrey C, Muses S, McClorey G, Wells KE, Coursindel T, Terry RL, Betts C, Hammond S, O'Donovan L, Hildyard J, El Andaloussi S, Gait MJ, Wood MJ, Wells DJ. Godfrey C, et al. Among authors: hammond s. Hum Mol Genet. 2015 Aug 1;24(15):4225-37. doi: 10.1093/hmg/ddv155. Epub 2015 May 1. Hum Mol Genet. 2015. PMID: 25935000 Free PMC article.

2

PRO-051, an antisense oligonucleotide for the potential treatment of Duchenne muscular dystrophy.

Hammond SM, Wood MJ. Hammond SM, et al. Curr Opin Mol Ther. 2010 Aug;12(4):478-86. Curr Opin Mol Ther. 2010. PMID: 20677099

3

PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation.

Ezzat K, Andaloussi SE, Zaghloul EM, Lehto T, Lindberg S, Moreno PM, Viola JR, Magdy T, Abdo R, Guterstam P, Sillard R, Hammond SM, Wood MJ, Arzumanov AA, Gait MJ, Smith CI, Hällbrink M, Langel Ü. Ezzat K, et al. Among authors: hammond sm. Nucleic Acids Res. 2011 Jul;39(12):5284-98. doi: 10.1093/nar/gkr072. Epub 2011 Feb 23. Nucleic Acids Res. 2011. PMID: 21345932 Free PMC article.

4

Genetic therapies for RNA mis-splicing diseases.

Hammond SM, Wood MJ. Hammond SM, et al. Trends Genet. 2011 May;27(5):196-205. doi: 10.1016/j.tig.2011.02.004. Epub 2011 Apr 15. Trends Genet. 2011. PMID: 21497936 Review.

5

Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice.

Yin H, Saleh AF, Betts C, Camelliti P, Seow Y, Ashraf S, Arzumanov A, Hammond S, Merritt T, Gait MJ, Wood MJ. Yin H, et al. Among authors: hammond s. Mol Ther. 2011 Jul;19(7):1295-303. doi: 10.1038/mt.2011.79. Epub 2011 Apr 19. Mol Ther. 2011. PMID: 21505427 Free PMC article.

6

Optimizing tissue-specific antisense oligonucleotide-peptide conjugates.

Betts CA, Hammond SM, Yin HF, Wood MJ. Betts CA, et al. Methods Mol Biol. 2012;867:415-35. doi: 10.1007/978-1-61779-767-5_27. Methods Mol Biol. 2012. PMID: 22454077

7

Use of cell-penetrating-peptides in oligonucleotide splice switching therapy.

El Andaloussi SA, Hammond SM, Mäger I, Wood MJ. El Andaloussi SA, et al. Curr Gene Ther. 2012 Jun;12(3):161-78. doi: 10.2174/156652312800840612. Curr Gene Ther. 2012. PMID: 22533378 Review.

8

Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment.

Betts C, Saleh AF, Arzumanov AA, Hammond SM, Godfrey C, Coursindel T, Gait MJ, Wood MJ. Betts C, et al. Mol Ther Nucleic Acids. 2012 Aug 14;1(8):e38. doi: 10.1038/mtna.2012.30. Mol Ther Nucleic Acids. 2012. PMID: 23344180 Free PMC article.

9

Design and application of bispecific splice-switching oligonucleotides.

Bestas B, McClorey G, Tedebark U, Moreno PM, Roberts TC, Hammond SM, Smith CI, Wood MJ, Andaloussi SE. Bestas B, et al. Nucleic Acid Ther. 2014 Feb;24(1):13-24. doi: 10.1089/nat.2013.0462. Nucleic Acid Ther. 2014. PMID: 24506779

10

Correlating In Vitro Splice Switching Activity With Systemic In Vivo Delivery Using Novel ZEN-modified Oligonucleotides.

Hammond SM, McClorey G, Nordin JZ, Godfrey C, Stenler S, Lennox KA, Smith CI, Jacobi AM, Varela MA, Lee Y, Behlke MA, Wood MJ, Andaloussi SE. Hammond SM, et al. Mol Ther Nucleic Acids. 2014 Nov 25;3(11):e212. doi: 10.1038/mtna.2014.63. Mol Ther Nucleic Acids. 2014. PMID: 25423116 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

993 results

Search Page

Filters